1. Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer
    Xiaocong Geng et al, 2017, PLOS ONE CrossRef
  2. A Pair of Prognostic Biomarkers in Triple-Negative Breast Cancer: KLK10 and KLK11 mRNA Expression
    Yueyang Liu et al, 2022, Life CrossRef
  3. miR-194-3p represses the docetaxel resistance in colon cancer by targeting KLK10
    Jinlai Zhao et al, 2022, Pathology - Research and Practice CrossRef
  4. Uncovering biomarkers for potential therapeutic targeting for COVID-19-related acute kidney injury: A bioinformatic approach
    Rui Gong et al, 2023, Journal of Translational Critical Care Medicine CrossRef
  5. Molecular subtypes identified by multiomics analysis based on cuproptosis‑related genes precisely predict response to immunotherapy and chemotherapy in colorectal cancer
    Dingling Li et al, 2023, Molecular Carcinogenesis CrossRef
  6. Kallikrein-related peptidases and associated microRNAs as promising prognostic biomarkers in gastrointestinal malignancies
    Panagiotis G. Adamopoulos et al, 2018, Biological Chemistry CrossRef
  7. Kallikrein-related peptidase 10 predicts prognosis and mediates tumor immunomodulation in colorectal cancer
    Yi-chao Luo et al, 2023, Biochemical and Biophysical Research Communications CrossRef
  8. RETRACTED ARTICLE: Long noncoding RNA HEIH depletion depresses esophageal carcinoma cell progression by upregulating microRNA-185 and downregulating KLK5
    Bing Wang et al, 2020, Cell Death & Disease CrossRef
  9. A 17-molecule set as a predictor of complete response to neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal cancer
    Hajime Fujishima et al, 2017, PLOS ONE CrossRef
  10. Transcriptional Suppression of miR-7 by MTA2 Induces Sp1-Mediated KLK10 Expression and Metastasis of Cervical Cancer
    Chia-Liang Lin et al, 2020, Molecular Therapy - Nucleic Acids CrossRef